Allina Health System | Strategic Alliance Partners

April 11, 2024

The experts provide their final thoughts surrounding the impact of prospective trials and therapy regimens for treating patients with refractory mCRC.

April 11, 2024

Key opportunities to improve the mCRC treatment landscape are illustrated by the expert panelists.

April 04, 2024

Dr Kim offers key perspective for MSI-high patients based on data presented at ASCO 2024.

April 04, 2024

Multiple abstracts from ESMO 2023, including a focus on tumor location, are highlighted.

March 28, 2024

Data presented at ESMO 2023 and ASCO GI 2024 highlight the impact of prior therapy, including VEGF inhibitors or fluoropyrimidine, on mCRC treatment approach.

March 28, 2024

Key factors, particularly neuropathy, drive the discussion for platinum-based therapy for patients with non-refractory mCRC.

March 21, 2024

Considerations for patients to receive aggressive mCRC therapy regimens are navigated by the panelists.

March 21, 2024

Side effect profiles driven by fruquintinib use are discussed.

March 14, 2024

Mark A Lewis, MD, and Scott Paulson, MD, share their experiences utilizing fruquintinib.

March 14, 2024

Richard Kim, MD, discusses the significance of real-world evidence when selecting treatment sequencing strategy.

March 07, 2024

Managing dose adjustments and tolerability in metastatic colorectal cancer (mCRC) treatment regimens for optimal efficacy is underscored.

March 07, 2024

Medical experts provide key takeaways and impacts from the FRESCO-2 study.

February 29, 2024

Marwan G Fakih, MD, drives a discussion highlighting a significant combination therapy in mCRC treatment.

February 29, 2024

Key safety considerations for the use of fruquintinib are explored.

February 22, 2024

Dr Parikh drives a conversation surrounding 3L treatment for patients diagnosed with metastatic colorectal cancer.

February 22, 2024

Medical experts open a discussion providing an update on the current impact of metastatic colorectal cancer and common treatment strategies.

December 19, 2023

Allina Health Cancer Institute is collaborating with St. Paul-based Astrin Biosciences for a first-of-its-kind clinical trial using artificial intelligence and a simple blood draw to revolutionize how cancer is diagnosed and treated.

August 25, 2022

Allina Health Cancer Institute is excited to offer its second annual Oncology Symposium on Friday, Sept. 23, 2022. The symposium brings together clinicians devoted to solving the disease of cancer and the many challenges associated with it.